The Danish Region Midt Schizophrenia Cohort
Recruiting · NCT06431009 · Observational (researchers observe without assigning treatment) · Lead sponsor: University of Aarhus
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The objective of this study is to recruit patients at the first diagnosis with a schizophrenia spectrum disorder (SSD) and ultra-high risk patients (UHR), defined as patients with drug abuse and psychotic symptoms indicating a risk for developing schizophrenia. Thereby, the investigators aim to establish a large representative cohort of patients with a first-episode SSD or patients at UHR, enabling investigations of the etiology and long-term prognosis of SSDs. The primary aim is to learn more about the importance of adverse childhood experiences (ACEs) and the immune system in the etiology and course of schizophrenia. Patients will be followed with planned visits after 1, 2, 3, 12 and 24 months including online questionnaires after 2, 6, 10 and 26 weeks. There will be the possibility to contact patients again for subsequent follow-up visits.
Who can take part
Inclusion criteria
- Age ≥15 years
- Diagnosed within the previous 3 months with first-episode SSD (ICD-10: F20-29) or UHR (ICD-10: F1X.5)
- Able to give informed oral and written consent.
Exclusion criteria
- Any coercive measure including patients in forensic psychiatry
- In a clinical condition where the treating clinician evaluates that the patient is not able to attend the research study.
Where it is running
5 locations listed.
- Aarhus University Hospital Psychiatry - Aarhus, Denmark
- Psychiatric Hospital Gødstrup - Herning, Denmark
- Psychiatric Hospital Horsens - Horsens, Denmark
- Psychiatric Hospital Randers - Randers, Denmark
- Psychiatric Hospital Midt - Silkeborg, Denmark